Transcriptional control of the human urothelial-specific gene, uroplakin Ia

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1729, Issue 2, 2005, Pages 126-134

  Hall, G D ^a   Weeks, R J ^a   Olsburgh, J ^a   Southgate, J ^a,b   Knowles, M A ^a   Selby, P J ^a   Chester, J D ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Gene therapy; Promoter; Tissue specific; Uroplakin 1a; Urothelial

Indexed keywords

LUCIFERASE; UNCLASSIFIED DRUG; UROPLAKIN; UROPLAKIN IA;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; GENE STRUCTURE; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN GENETICS; HUMAN TISSUE; IN VITRO STUDY; INTRON; MOLECULAR CLONING; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UROTHELIUM;

5' FLANKING REGION; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION SITE;

EID: 20444425632     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2005.04.004     Document Type: Article

References (43)

1. T. Walz, M. Haner, X.R. Wu, C. Henn, A. Engel, T.T. Sun, and U. Aebi Towards the molecular architecture of the asymmetric unit membrane of the mammalian urinary bladder epithelium: a closed "twisted ribbon" structure J. Mol. Biol. 248 1995 887 900
2. X.R. Wu, M. Manabe, J. Yu, and T.T. Sun Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation J. Biol. Chem. 265 1990 19170 19179
3. J. Yu, M. Manabe, X.R. Wu, C. Xu, B. Surya, and T.T. Sun Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium J. Cell Biol. 111 1990 1207 1216
4. X.R. Wu, and T.T. Sun Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein J. Cell Sci. 106 Pt. 1 1993 31 43
5. J.H. Lin, X.R. Wu, G. Kreibich, and T.T. Sun Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane J. Biol. Chem. 269 1994 1775 1784
6. X.R. Wu, J.H. Lin, T. Walz, M. Haner, J. Yu, U. Aebi, and T.T. Sun Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins J. Biol. Chem. 269 1994 13716 13724
7. J. Yu, J.H. Lin, X.R. Wu, and T.T. Sun Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins J. Cell Biol. 125 1994 171 182
8. T.T. Sun, H. Zhao, J. Provet, U. Aebi, and X.R. Wu Formation of asymmetric unit membrane during urothelial differentiation Mol. Biol. Rep. 23 1996 3 11
9. R. Moll, X.R. Wu, J.H. Lin, and T.T. Sun Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas Am. J. Pathol. 147 1995 1383 1397
10. E.D. Lobban, B.A. Smith, G.D. Hall, P. Harnden, P. Roberts, P.J. Selby, L.K. Trejdosiewicz, and J. Southgate Uroplakin gene expression by normal and neoplastic human urothelium Am. J. Pathol. 153 1998 1957 1967
11. R.L. Wu, I. Osman, X.R. Wu, M.L. Lu, Z.F. Zhang, F.X. Liang, R. Hamza, H. Scher, C. Cordon-Cardo, and T.T. Sun Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation Cancer Res. 58 1998 1291 1297
12. J.L. Finch, J. Miller, J.O. Aspinall, and P.A. Cowled Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue Int. J. Cancer 80 1999 533 538
13. S. Kageyama, T. Yoshiki, T. Isono, T. Tanaka, C.J. Kim, T. Yuasa, and Y. Okada High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma Jpn. J. Cancer Res. 93 2002 523 531
14. J. Olsburgh, P. Harnden, R. Weeks, B. Smith, A. Joyce, G. Hall, R. Poulsom, P. Selby, and J. Southgate Uroplakin gene expression in normal human tissues and locally advanced bladder cancer J. Pathol. 199 2003 41 49
15. M.J. Seraj, A.R. Thomas, J.L. Chin, and D. Theodorescu Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder Clin. Cancer Res. 7 2001 1516 1522
16. X. Xu, T.T. Sun, P.K. Gupta, P. Zhang, and J.F. Nasuti Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens Cancer 93 2001 216 221
17. T. Yuasa, T. Yoshiki, T. Tanaka, C.J. Kim, T. Isono, and Y. Okada Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma Jpn. J. Cancer Res. 89 1998 879 882
18. S.M. Li, Z.T. Zhang, S. Chan, O. McLenan, C. Dixon, S. Taneja, H. Lepor, T.T. Sun, and X.R. Wu Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder J. Urol. 162 1999 931 935
19. T. Yuasa, T. Yoshiki, T. Isono, T. Tanaka, H. Hayashida, and Y. Okada Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients Int. J. Urol. 6 1999 286 292
20. J.J. Lu, Y. Kakehi, T. Takahashi, X.X. Wu, T. Yuasa, T. Yoshiki, Y. Okada, T. Terachi, and O. Ogawa Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer Clin. Cancer Res. 6 2000 3166 3171
21. J.R. Masters, P.J. Hepburn, L. Walker, W.J. Highman, L.K. Trejdosiewicz, S. Povey, M. Parkar, B.T. Hill, P.R. Riddle, and L.M. Franks Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines Cancer Res. 46 1986 3630 3636
22. J. Southgate, K.A. Hutton, D.F. Thomas, and L.K. Trejdosiewicz Normal human urothelial cells in vitro: proliferation and induction of stratification Lab. Invest. 71 1994 583 594
23. W.M. Schmidt, and M.W. Mueller CapSelect: a highly sensitive method for 5′ CAP-dependent enrichment of full-length cDNA in PCR-mediated analysis of mRNAs Nucleic Acids Res. 27 1999 e31
24. P. Bucher Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences J. Mol. Biol. 212 1990 563 578
25. J. Olsburgh, G. Hall, P. Harnden, R. Poulsom, P. Selby, and J. Southgate Uroplakin expression in muscle-invasive and locally metastatic transitional cell carcinoma and normal human tissues Proceedings of the American Association of Cancer Research vol. 42 2001 799 Abstract 4289
26. J. Olsburgh, R. Weeks, P. Selby, and J. Southgate Human uroplakin lb gene structure and promoter analysis Biochim. Biophys. Acta 1576 2002 163 170
27. J. Zhang, N. Ramesh, Y. Chen, Y. Li, J. Dilley, P. Working, and D.C. Yu Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel Cancer Res. 62 2002 3743 3750
28. M. Torres, E. Gomez-Pardo, G.R. Dressler, and P. Gruss Pax-2 controls multiple steps of urogenital development Development 121 1995 4057 4065
29. N. Miyamoto, M. Yoshida, S. Kuratani, I. Matsuo, and S. Aizawa Defects of urogenital development in mice lacking Emx2 Development 124 1997 1653 1664
30. R.S. Peterson, D.E. Clevidence, H. Ye, and R.H. Costa Hepatocyte nuclear factor-3 alpha promoter regulation involves recognition by cell-specific factors, thyroid transcription factor-1, and autoactivation Cell Growth Differ. 8 1997 69 82
31. W. Kopachik, S.W. Hayward, and G.R. Cunha Expression of hepatocyte nuclear factor-3alpha in rat prostate, seminal vesicle, and bladder Dev. Dyn. 211 1998 131 140
32. E.E. Morrisey, H.S. Ip, M.M. Lu, and M.S. Parmacek GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm Dev. Biol. 177 1996 309 322
33. Y. Guan, Y. Zhang, L. Davis, and M.D. Breyer Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans Am. J. Physiol. 273 1997 F1013 F1022
34. S. Jain, S. Pulikuri, Y. Zhu, C. Qi, Y.S. Kanwar, A.V. Yeldandi, M.S. Rao, and J.K. Reddy Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse Am. J. Pathol. 153 1998 349 354
35. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
36. C.L. Varley, J. Stahlschmidt, W.C. Lee, J. Holder, C. Diggle, P.J. Selby, L.K. Trejdosiewicz, and J. Southgate Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme J. Cell Sci. 117 2004 2029 2036
37. R.G. Vile, and I.R. Hart In vitro and in vivo targeting of gene expression to melanoma cells Cancer Res. 53 1993 962 967
38. R.G. Vile, and I.R. Hart Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequences Ann. Oncol. 5 Suppl. 4 1994 59 65
39. M. Artuc, W. Nurnberg, B.M. Czarnetzki, and D. Schadendorf Characterization of gene regulatory elements for selective gene expression in human melanoma cells Biochem. Biophys. Res. Commun. 213 1995 699 705
40. R.M. Diaz, T. Eisen, I.R. Hart, and R.G. Vile Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma J. Virol. 72 1998 789 795
41. J. Cheon, S.C. Ko, T.A. Gardner, T. Shirakawa, A. Gotoh, C. Kao, and L.W. Chung Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model Cancer Gene Ther. 4 1997 359 365
42. C. Wei, R.A. Willis, B.R. Tilton, R.J. Looney, E.M. Lord, R.K. Barth, and J.G. Frelinger Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy Proc. Natl. Acad. Sci. U. S. A. 94 1997 6369 6374
43. B.E. Huber, C.A. Richards, and T.A. Krenitsky Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy Proc. Natl. Acad. Sci. U. S. A. 88 1991 8039 8043